NASDAQ:MARK

Remark (MARK) Stock Price, News & Analysis

$0.12
0.00 (0.00%)
(As of 05/3/2024 ET)
Today's Range
$0.12
$0.13
50-Day Range
$0.12
$0.37
52-Week Range
$0.11
$1.83
Volume
170,130 shs
Average Volume
333,715 shs
Market Capitalization
$5.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MARK stock logo

About Remark Stock (NASDAQ:MARK)

Remark Holdings, Inc. primarily focuses on the development and deployment of artificial intelligence-based solutions for businesses and software developers. It operates a data and AI software platform that offers AI-based computer vision products, computing devices, and software-as-a-service solutions; and Smart Safety Platform, a software solution that uses computer vision to detect persons, objects, and behavior in video feeds, as well as provides Remark AI Thermal kits and rPad products and services. It serves retail, hospitality, construction, public safety, workplace safety, and public sectors. The company was formerly known as Remark Media, Inc. and changed its name to Remark Holdings, Inc. in April 2017. Remark Holdings, Inc. was incorporated in 2006 and is headquartered in Las Vegas, Nevada.

MARK Stock Price History

MARK Stock News Headlines

Never use this word on your phone (FBI could be watching)
This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...
Q4 2023 Remark Holdings Inc Earnings Call
Never use this word on your phone (FBI could be watching)
This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...
Remark Holdings Announces Listing on OTC Pink Market
Remark Holdings Announces Listing on OTC Pink Market
Why Is Remark (MARK) Stock Down 45% Today?
Q3 2023 Remark Holdings Inc Earnings Call
See More Headlines
Receive MARK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Remark and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/15/2024
Today
5/05/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Communication services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:MARK
Employees
88
Year Founded
N/A

Profitability

Net Income
$-29,150,000.00
Net Margins
-662.13%
Pretax Margin
-662.13%

Debt

Sales & Book Value

Annual Sales
$5.81 million
Book Value
($1.89) per share

Miscellaneous

Free Float
41,862,000
Market Cap
$5.50 million
Optionable
Optionable
Beta
2.66
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

MARK Stock Analysis - Frequently Asked Questions

How have MARK shares performed in 2024?

Remark's stock was trading at $0.4952 at the start of the year. Since then, MARK shares have decreased by 75.0% and is now trading at $0.1237.
View the best growth stocks for 2024 here
.

When is Remark's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our MARK earnings forecast
.

How were Remark's earnings last quarter?

Remark Holdings, Inc. (NASDAQ:MARK) issued its earnings results on Monday, April, 15th. The information services provider reported ($0.36) EPS for the quarter. The information services provider earned $0.23 million during the quarter.

What is Kai-Shing Tao's approval rating as Remark's CEO?

6 employees have rated Remark Chief Executive Officer Kai-Shing Tao on Glassdoor.com. Kai-Shing Tao has an approval rating of 67% among the company's employees.

What other stocks do shareholders of Remark own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Remark investors own include Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), Heat Biologics (HTBX), Organigram (OGI), Genius Brands International (GNUS), Matinas BioPharma (MTNB), Vaxart (VXRT), Bionano Genomics (BNGO), Tilly's (TLYS) and Novan (NOVN).

Who are Remark's major shareholders?

Remark's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Cutter & CO Brokerage Inc. (11.00%).
View institutional ownership trends
.

How do I buy shares of Remark?

Shares of MARK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MARK) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners